Off-Label Use of Drugs and Devices in the Neuroendovascular Suite

REFERENCES

1. 1.↵
   FDA. “Off-Label” and Investigational Use of Marketed Drugs, Biologics, and Medical Devices: Information Sheet. August 10, 2011. http://www.fda.gov/RegulatoryInformation/Guidances/ucm126486.htm. Accessed April 10, 2012
2. 2.↵
   1. Parsons M.,
   2. Spratt N.,
   3. Bivard A.,
   4. et al

   . A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med 2012;366:1099–107

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Chaudhary N.,
   2. Pandey AS.,
   3. Gemmete JJ

   . Intervention in acute cerebral ischemic stroke: a review of the role of pharmacological therapies and intra-arterial mechanical thrombectomy devices. Postgrad Med J 2011;87:714–23

   Abstract/FREE Full Text
4. 4.↵
   1. Lee M,
   2. Hong KS,
   3. Saver JL

   . Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke 20102:41:932–37
5. 5.↵
   1. Qureshi A.,
   2. Luft A,
   3. Sharma M,
   4. et al

   . Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: part I. Pathophysiological and pharmacological features. Neurosurgery 2000;46:1344–59

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Castelluci L

   . FDA reapproves urokinase. October 11, 2002. The heart.org. http://www.theheart.org/article/266091.do. Accessed July 10, 2012
7. 7.↵
   1. Furlan A,
   2. Higashida R,
   3. Wechsler L,
   4. et al

   . Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study—a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11

   CrossRefPubMedWeb of Science
8. 8.↵
   1. del Zoppo GJ,
   2. Higashida RT,
   3. Furlan AJ.,
   4. et al

   . PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4–11

   Abstract/FREE Full Text
9. 9.↵
   1. Lee M,
   2. Hon KS.,
   3. Saver J

   . Efficacy of intra-arterial fibrinolysis for acute ischemic stroke meta-analysis of randomized controlled trials. Stroke 2010;41:932–37

   Abstract/FREE Full Text
10. 10.↵
    1. Biondi A,
    2. Ricciardi GK,
    3. Puybasset L,
    4. et al

    . Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol 2004;25:1067–76

    Abstract/FREE Full Text
11. 11.↵
    1. Qureshi AI,
    2. Pande R,
    3. Kim S,
    4. et al

    . Third generation thrombolytics for the treatment of ischemic stroke. Curr Opin Investig Drugs 2002;3:1729–32

    PubMed
12. 12.↵
    1. Topol EJ

    . Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet 2001;357:1905–14

    CrossRefPubMedWeb of Science
13. 13.↵
    The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998;352:87–92

    CrossRefPubMedWeb of Science
14. 14.↵
    The CAPTURE Investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 1997;349:1429–35

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Walsh R,
    2. Barrett K,
    3. Aguilar M,
    4. et al

    . Intracranial hemorrhage following neuroendovascular procedures with abciximab is associated with high mortality: a multicenter series. Neurocrit Care 2011;15:85–95

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Memon M,
    2. Natarajan S,
    3. Sharma J,
    4. et al

    . Safety and feasibility of intraarterial eptifibatide as a revascularization tool in acute ischemic stroke. J Neurosurg 2011;114:1008–13

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Ries T,
    2. Siemonsen S,
    3. Grzyska U,
    4. et al

    . Abciximab is a safe rescue therapy in thromboembolic events complicating cerebral aneurysm coil embolization: single center experience in 42 cases and review of the literature. Stroke 2009;40:1750–57

    Abstract/FREE Full Text
18. 18.↵
    1. Adams HP Jr.,
    2. Effron MB,
    3. Torner J,
    4. et al.

    , for the AbESTT-II Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008;39:87–99

    Abstract/FREE Full Text
19. 19.↵
    1. Hofmann R,
    2. Kerschner K,
    3. Steinwender C,
    4. et al

    . Abciximab bolus injection does not reduce cerebral ischemic complications of elective carotid artery stenting: a randomized study. Stroke 2002;33:725–27

    Abstract/FREE Full Text
20. 20.↵
    1. Chan AW,
    2. Yadav JS,
    3. Bhatt DL,
    4. et al

    . Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stenting. Am J Cardiol 2005;95:791–95

    CrossRefPubMed
21. 21.↵
    1. Wholey MH,
    2. Wholey MH,
    3. Eles G,
    4. et al

    . Evaluation of glycoprotein IIb/IIIa inhibitors in carotid angioplasty and stenting. J Endovasc Ther 2003;10:33–41

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Qureshi AI,
    2. Saad M,
    3. Zaidat OO,
    4. et al

    . Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke 2002;33:1916–19

    Abstract/FREE Full Text
23. 23.↵
    1. Katsaridis V,
    2. Papagiannaki C,
    3. Skoulios N,
    4. et al

    . Local intra-arterial eptifibatide for intraoperative vessel thrombosis during aneurysm coiling. AJNR Am J Neuroradiol 2008;29:1414–17

    Abstract/FREE Full Text
24. 24.↵
    1. Park JH,
    2. Kim JE.,
    3. Sheen SH,
    4. et al

    . Intraarterial abciximab for treatment of thromboembolism during coil embolization of intracranial aneurysms: outcome and fatal hemorrhagic complications. J Neurosurg 2008;108:450–57

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Chun R,
    2. Orser B,
    3. Madan M

    . Platelet glycoprotein IIb/IIIa inhibitors: overview and implications for the anesthesiologist. Anesth Analg 2002;95:879–88

    PubMedWeb of Science
26. 26.↵
    1. Lincoff AM,
    2. Topol EJ

    , eds. Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease. Totowa, New Jersey: Humana Press; 1999:169–97
27. 27.↵
    1. Bhatt D,
    2. Topol E

    . Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. JAMA 2000;284:1549–58

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Dorhout Mees SM,
    2. Rinkel G,
    3. Feigin V,
    4. et al

    . Calcium antagonists for aneurysmal subarachnoid hemorrhage. Cochrane Database Syst Rev 2007:CD000277
29. 29.↵
    1. Pickard JD,
    2. Murray GD,
    3. Illingworth R,
    4. et al

    . Effect of oral nimodipine on cerebral infraction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 1989;298:636–42

    Abstract/FREE Full Text
30. 30.↵
    1. Barker F,
    2. Ogilvy C

    . Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 1996:84:405–14

    CrossRefPubMedWeb of Science
31. 31.↵
    FDA Labeling Text. Nimtop (nimodipine) capsules for oral use. January 20, 2006. http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/018869s014lbl.pdf. Accessed June 7, 2012
32. 32.↵
    1. Kronvall E,
    2. Undren P,
    3. Romner B,
    4. et al

    . Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration. J Neurosurg 2009;110:58–63

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Jan M,
    2. Buchneit F,
    3. Tremoulet M

    . Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms. Neurosurgery 1988;23:154–57

    CrossRefPubMed
34. 34.↵
    1. Rosenberg N,
    2. Lazzaro MA,
    3. Lopes DK,
    4. et al

    . High-dose intra-arterial nicardipine results in hypotension following vasospasm treatment in subarachnoid hemorrhage. Neurocrit Care 2011;15:400–04

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Keuskamp J,
    2. Murali R,
    3. Chao K

    . High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 2008;108:458–63

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Taccone FS

    . Vasodilation and neuroprotection: the magnesium saga in subarachnoid hemorrhage. Crit Care Med 2010;38:1382–84

    CrossRefPubMed
37. 37.↵
    1. Suarez JI

    , for Participants in the International Multidisciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Magnesium sulfate administration in subarachnoid hemorrhage. Neurocrit Care 2011;15:302–07

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Shah Q,
    2. Memom M,
    3. Suri MF,
    4. et al

    . Super-selective intra-arterial magnesium sulfate in combination with nicardipine for the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Neurocrit Care 2009;11:190–98

    CrossRefPubMed
39. 39.↵
    1. Zaidat O

    . Periprocedural management of patients with endovascular treatment of intracranial atherosclerotic disease. J Neuroimaging 2009;19:35S–38S

    CrossRefPubMed
40. 40.↵
    1. Vance AZ,
    2. Jayaraman MV,
    3. Dubel GJ,
    4. et al

    . Safety of intravenous heparin administration after endovascular treatment of ruptured intracranial aneurysms. J Neurointervent Surg 2009;1:136–41

    Abstract/FREE Full Text
41. 41.↵
    1. Hussein HM,
    2. Geordiadis AL,
    3. Qureshi AI

    . Point of care testing of anticoagulation monitoring in neuroendovascular procedures. AJNR Am J Neuroradiol 2012;33:1211–20

    Abstract/FREE Full Text
42. 42.↵
    1. Di Nisio M,
    2. Middeldorp S,
    3. Büller H

    . Direct thrombin inhibitors. N Engl J Med 2005;353:1028–40

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Hassan AE,
    2. Memon M,
    3. Georgiadis A,
    4. et al

    . Safety and tolerability of high-intensity anticoagulation with bivalirudin during neuroendovascular procedures. Neurocrit Care 2011;15:96–100

    CrossRefPubMed
44. 44.↵
    1. Pandya DJ,
    2. Fitzsimmons BF,
    3. Wolfe TJ,
    4. et al

    . Measurement of antiplatelet inhibition during neurointerventional procedures: the effect of antithrombotic duration and loading dose. J Neuroimaging 2010;20:64–69

    CrossRefPubMedWeb of Science
45. 45.↵
    1. van den Bergh WM,
    2. Kerr RS,
    3. Algra A,
    4. et al.

    , for the International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. Effect of antiplatelet therapy for endovascular coiling in aneurysmal subarachnoid hemorrhage. Stroke 2009;40:1969–72

    Abstract/FREE Full Text
46. 46.↵
    1. Yamada NK,
    2. Cross DT 3rd.,
    3. Pilgram TK,
    4. et al

    . Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms. AJNR Am J Neuroradiol 2007;28:1778–82

    Abstract/FREE Full Text
47. 47.↵
    1. Kang HS,
    2. Han M,
    3. Kwon B,
    4. et al

    . Is clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms? Neurosurgery 2010;67:1371–76

    CrossRefPubMedWeb of Science
48. 48.↵
    Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership. Highlights of Prescribing Information. December 2012, 2012. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020839s055lbl.pdf. Accessed July 3, 2012
49. 49.↵
    1. Mas JL,
    2. Trinquart L,
    3. Leys D,
    4. et al

    . Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol 2008;7:885–92

    CrossRefPubMedWeb of Science
50. 50.↵
    1. Hassan AE,
    2. Zacharatos H,
    3. Vazquez G,
    4. et al

    . Low risk of intracranial and systemic hemorrhages in patients on dual antiplatelet treatment beyond 1 month following neuroendovascular angioplasty and/or stent placement. J Neuroimaging 2012;22:67–73

    CrossRefPubMedWeb of Science
51. 51.↵
    1. Qureshi AI,
    2. Feldmann E,
    3. Gomez CR,
    4. et al

    . Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results. J Neuroimaging 2009;19(suppl 1):1S–10S

    CrossRefWeb of Science
52. 52.↵
    1. Chimowitz MI,
    2. Lynn MJ,
    3. Derdeyn CP

    , for the SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993–1003

    CrossRefPubMedWeb of Science
53. 53.↵
    1. Brott TG,
    2. Hobson RW II.,
    3. Howard G,
    4. et al.

    for the CREST Investigators. Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis. N Engl J Med 2010;363:11–23

    CrossRefPubMedWeb of Science
54. 54.↵
    1. Yadav JS,
    2. Wholey MH,
    3. Kuntz RE,
    4. et al.

    for the Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493–501

    CrossRefPubMedWeb of Science
55. 55.↵
    1. Ederle J,
    2. Dobson J,
    3. Featherstone RL,
    4. et al.

    for the International Carotid Stenting Study investigators. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet 2010;375:985–997

    CrossRefPubMedWeb of Science
56. 56.↵
    1. Ringleb PA,
    2. Allenberg J,
    3. Brückmann H,
    4. et al.

    for the SPACE Collaborative Group. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006;368;1239–47

    CrossRefPubMedWeb of Science
57. 57.↵
    1. Costalat V,
    2. Maldonado IL,
    3. Zerlauth JB,
    4. et al

    . Endovascular treatment of symptomatic intracranial arterial stenosis: six-year experience in a single-center series of 42 consecutive patients with acute and mid-term results. Neurosurgery 2010;67:1505–13

    CrossRefPubMedWeb of Science
58. 58.↵
    1. Jiang WJ,
    2. Wang YJ,
    3. Du B,
    4. et al

    . Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke 2004;35:1375–80

    Abstract/FREE Full Text
59. 59.↵
    1. Lylyk P,
    2. Vila JF,
    3. Miranda C,
    4. et al

    . Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol Res 2005;27(suppl 1):S84–88

    CrossRefPubMedWeb of Science
60. 60.↵
    1. Mori T,
    2. Kazita K,
    3. Chokyu K,
    4. et al

    . Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR J Neuroradiol 2000;21:249–54
61. 61.↵
    1. Fiorella D,
    2. Chow MM,
    3. Anderson M,
    4. et al

    . A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 2007;61:236–42

    CrossRefPubMedWeb of Science
62. 62.↵
    1. Gupta R,
    2. Al-Ali F,
    3. Thomas AJ,
    4. et al

    . Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 2006;37:2562–66

    Abstract/FREE Full Text
63. 63.↵
    1. Abou-Chebl A,
    2. Bashir Q,
    3. Yadav JS

    . Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke 2005;36:e165–68

    Abstract/FREE Full Text
64. 64.↵
    1. Vajda Z,
    2. Guthe T,
    3. Perez MA

    . Neurovascular in-stent stenoses: treatment with conventional and drug-eluting balloons. AJNR Am J Neuroradiol 2011;32:1942–47

    Abstract/FREE Full Text
65. 65.↵
    1. Fields JD,
    2. Petersen BD,
    3. Lutsep HL,
    4. et al

    . Drug eluting stents for symptomatic intracranial and vertebral artery stenosis. Interv Neuroradiol 2011;17:241–47

    Abstract/FREE Full Text
66. 66.↵
    1. Siddiq F,
    2. Vasquez G,
    3. Memon M,
    4. et al

    . Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases a multicenter study. Stroke 2008;39:2505–10

    Abstract/FREE Full Text
67. 67.↵
    The SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA). Stroke 2004;35:1388–92

    Abstract/FREE Full Text
68. 68.↵
    1. Takayama T,
    2. Hiro T,
    3. Hirayama A

    . Stent thrombosis and drug-eluting stents. J Cardiol 2011;58:92–98

    CrossRefPubMed
69. 69.↵
    1. Derdeyn C,
    2. Chimowitz M

    . Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N Am 2007;17:355–63, viii-ix

    CrossRefPubMedWeb of Science
70. 70.↵
    1. Ding D,
    2. Liu KC

    . Applications of stenting for intracranial atherosclerosis. Neurosurg Focus 2011;30:E15

    PubMed
71. 71.↵
    1. King SB 3rd.,
    2. Smith SC Jr.,
    3. Hirshfeld JW Jr.,
    4. et al

    . 2007 Focused update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines—2007 writing group to review new evidence and update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary, Writing on Behalf of the 2005 Writing Committee. Circulation 2008;117:261–295

    FREE Full Text
72. 72.↵
    1. Cruz-Flores S,
    2. Diamond AL

    . Angioplasty for intracranial artery stenosis. Cochrane Database Syst Rev 2006;CD004133
73. 73.↵
    1. Qureshi AI,
    2. Tariq N,
    3. Hassan AE,
    4. et al

    . Predictors and timing of neurological complications following intracranial angioplasty and/or stent placement. Neurosurgery 2011;68:53–60

    CrossRefPubMedWeb of Science
74. 74.↵
    1. Kurre W,
    2. Brassel F,
    3. Bruning R,
    4. et al.

    , for the INTRASTENT study group. Complication rates using balloon-expandable and self-expanding stents for the treatment of intracranial atherosclerotic stenoses: analysis of the INTRASTENT multicentric registry. Neuroradiology 2012;54:43–50

    CrossRefPubMedWeb of Science
75. 75.↵
    1. Jiang W,
    2. Xu X,
    3. Jin M,
    4. et al

    . Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results. AJNR Am J Neuroradiol 2007;28:830–34

    Abstract/FREE Full Text
76. 76.↵
    1. Siddiq F,
    2. Memon M,
    3. Vazquez G,
    4. et al

    . Comparison between primary angioplasty and stent placement for symptomatic intracranial atherosclerotic disease: meta-analysis of case series. Neurosurgery 2009;65:1024–33

    CrossRefPubMedWeb of Science
77. 77.↵
    1. Hauck E.,
    2. Natarajan S.,
    3. Horvathy D,
    4. et al

    . Stent-assisted basilar reconstruction for a traumatic vertebral dissection with a large basilar artery thrombosis. J Neurointerv Surg 2011;3:47–49

    Abstract/FREE Full Text
78. 78.↵
    1. Yi A,
    2. Palmer E,
    3. Luh G,
    4. et al

    . Endovascular treatment of carotid and vertebral pseudoaneurysms with covered stents. AJNR Am J Neuroradiol 2008;29:983–87

    Abstract/FREE Full Text
79. 79.↵
    1. Kadkhodayan Y,
    2. Jeck D,
    3. Moran C,
    4. et al

    . Angioplasty and stenting in carotid dissection with or without associated pseudoaneurysm. AJNR Am J Neuroradiol 2005;26:2328–35

    Abstract/FREE Full Text
80. 80.↵
    1. Hassan AE,
    2. Zacharatos H,
    3. Souslian F,
    4. et al

    . Long-term clinical and angiographic outcomes in patients with cervico-cranial dissections treated with stent placement: a meta-analysis of case series. J Neurotrauma 2012;29:1342–53

    CrossRefPubMedWeb of Science
81. 81.↵
    1. Kan P,
    2. Mokin M,
    3. Dumont T,
    4. et al

    . Cervical carotid artery stenosis: latest update on diagnosis and management. Curr Probl Cardiol 2012;37:127–69

    CrossRefPubMed
82. 82.↵
    1. Brooks W,
    2. McClure R,
    3. Jones M,
    4. et al

    . Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital. J Am Coll Cardiol 2001;38:1589–95

    CrossRefPubMedWeb of Science
83. 83.↵
    1. Parodi J,
    2. La Mura R,
    3. Ferreira L,
    4. et al

    . Initial evaluation of carotid angioplasty and stenting with three different cerebral protection devices. J Vasc Surg 2000;32:1127–36

    CrossRefPubMedWeb of Science
84. 84.↵
    1. Wichman HJ,
    2. Rowe VL

    . Percutaneous transluminal angioplasty balloons. Medscape. February 15, 2012. http://emedicine.medscape.com/article/2035433-overview#aw2aab6b2. Accessed July 13, 2012
85. 85.↵
    1. Terry A,
    2. Zipfel G,
    3. Milner E,
    4. et al

    . Safety and technical efficacy of over-the-wire balloons for the treatment of subarachnoid hemorrhage-induced cerebral vasospasm. Neurosurg Focus 2006;21:E14

    PubMed
86. 86.↵
    1. Eskridge JM,
    2. McAuliffe W,
    3. Song JK,
    4. et al

    . Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurgery 1998;42:510–16, discussion 516–17

    CrossRefPubMedWeb of Science
87. 87.↵
    1. Zubkov YN,
    2. Alexander LF,
    3. Smith RR,
    4. et al

    . Angioplasty of vasospasm: is it reasonable? Neurol Res 1994;16:9–11

    PubMed
88. 88.↵
    1. Miley J,
    2. Tariq N,
    3. Souslian F,
    4. et al

    . Comparison between angioplasty using compliant and noncompliant balloons for treatment of cerebral vasospasm associated with subarachnoid hemorrhage. Neurosurgery 2011;69(2 suppl operative):ons161–68, discussion ons168

    PubMed
89. 89.↵
    1. Newell DW,
    2. Eskridge J,
    3. Mayberg M,
    4. et al

    . Endovascular treatment of intracranial aneurysms and cerebral vasospasm. Clin Neurosurg 1992;39:348–60

    PubMed
90. 90.↵
    1. Eskridge JM,
    2. Newell DW,
    3. Pendleton GA

    . Transluminal angioplasty for treatment of vasospasm. Neurosurg Clin N Am 1990;1:387–99

    PubMed
91. 91.↵
    1. Sano K,
    2. Takakura K,
    3. Kassell N,
    4. et al

    1. Takahashi A,
    2. Yoshoto T,
    3. Mizou K,
    4. et al

    . Transluminal balloon angioplasty for cerebral vasospasm after subarachnoid hemorrhage. In: Sano K, Takakura K, Kassell N, et al. (eds). Cerebral Vasospasm, Tokyo: University of Tokyo Press; 1990, pp. 429–32
92. 92.↵
    1. Zacharatos H,
    2. Hassan AE,
    3. Qureshi AI

    . Intravascular ultrasound: principles and cerebrovascular applications. AJNR Am J Neuroradiol 2010;31:586–97

    Abstract/FREE Full Text
93. 93.↵
    1. Clark DJ,
    2. Lessio S,
    3. O'Donoghue M,
    4. et al

    . Safety and utility of intravascular ultrasound guided carotid artery stenting. Catheter Cardiovasc Interv 2004;63:355–62

    CrossRefPubMedWeb of Science
94. 94.↵
    1. Weissman N,
    2. Canos M,
    3. Mintz G,
    4. et al

    . Carotid artery intravascular ultrasound: safety and morphologic observations during carotid stenting in 102 patients. J Am Coll Cardiol 2000;35(2 supple 1):10A
95. 95.↵
    1. Manninen HI,
    2. Räsänen H,
    3. Vanninen RL,
    4. et al

    . Human carotid arteries: correlation of intravascular US with angiographic and histopathologic findings. Radiology 1998;206:65–74

    CrossRefPubMedWeb of Science
96. 96.↵
    1. Kan P,
    2. Mokin M,
    3. Abla AA,
    4. et al

    . Utility of intravascular ultrasound in intracranial and extracranial neurointerventions: experience at University at Buffalo Neurosurgery-Millard Fillmore Gates Circle Hospital. Neurosurg Focus 2012;2:E6
97. 97.↵
    1. Quershi AI

    1. Strozyk D,
    2. Baccin CE,
    3. Pryor JC,
    4. et al

    . Intracranial arteriovenous malformations. In: Quershi AI , ed. Textbook of Interventional Neurology. New York: Cambridge University Press; 2011:255
98. 98.↵
    1. Oh D,
    2. Hirsch J,
    3. Yoo A

    . Novel use of Onyx for treatment of intracranial vertebral artery dissection. J Neurointerv Surg 2012;4:31–33

    Abstract/FREE Full Text
99. 99.↵
    1. Tevah J,
    2. Senf R,
    3. Cruz J,
    4. et al

    . Endovascular treatment of complex cerebral aneurysms with Onyx HD-500 in 38 patients. J Neuroradiol 2011;38:283–90

    CrossRefPubMedWeb of Science
100. 100.↵
     1. Simon SD,
     2. Lopes DK,
     3. Mericle RA

     . Use of intracranial stenting to secure unstable liquid embolic casts in wide-neck sidewall intracranial aneurysms. Neurosurgery 2010;66(3 suppl operative):92–97, discussion 97–98

     CrossRefPubMedWeb of Science
101. 101.↵
     1. Medel R,
     2. Crowley RW,
     3. Hamilton DK,
     4. et al

     . Endovascular obliteration of an intracranial pseudoaneurysm: the utility of Onyx. J Neurosurg Pediatr 2009;4:445–48

     CrossRefPubMed
102. 102.↵
     1. Eddleman CS,
     2. Surdell D,
     3. DiPatri A Jr.,
     4. et al

     . Infectious intracranial aneurysms in the pediatric population: endovascular treatment with Onyx. Childs Nerv Syst 2008;24:909–15

     CrossRefPubMedWeb of Science
103. 103.↵
     1. Isokangas JM,
     2. Siniluoto T,
     3. Tikkakoski T,
     4. et al

     . Endovascular treatment of peripheral aneurysms of the posterior inferior cerebellar artery. AJNR Am J Neuroradiol 2008;29:1783–88

     Abstract/FREE Full Text
104. 104.↵
     1. Choulakian A,
     2. Drazin D,
     3. Alexander MJ

     . NBCA embolization of a ruptured intraventricular distal anterior choroidal artery aneurysm in a patient with Moyamoya disease. J Neurointerv Surg 2010;2:368–70

     Abstract/FREE Full Text
105. 105.↵
     1. Larrazabal R,
     2. Pelz D,
     3. Findlay JM

     . Endovascular treatment of a lenticulostriate artery aneurysm with N-butyl cyanoacrylate. Can J Neurol Sci 2001;28:256–59

     CrossRefPubMedWeb of Science
106. 106.↵
     1. Kim SH,
     2. Kwon O-Ki,
     3. Jung CK,
     4. et al

     . Endovascular treatment of ruptured aneurysms of pseudoaneurysms on the collateral vessels in patients with Moyamoya disease. Neurosurgery 2009;65:1000–04

     CrossRefPubMedWeb of Science
107. 107.↵
     1. Piske RL,
     2. Kanashiro LH,
     3. Paschoal E,
     4. et al

     . Evaluation of Onyx HD-500 embolic system in the treatment of 84 wide-neck intracranial aneurysms. Neurosurgery 2009;64:E865–75

     CrossRefPubMed
108. 108.↵
     1. Dudeck O,
     2. Jordan O.,
     3. Hoffmann KT,
     4. et al

     . Embolization of experimental wide-necked aneurysms with iodine-containing polyvinyl alcohol solubilized in a low-angiotoxicity solvent. AJNR Am J Neuroradiol 2006;27:1849–55

     Abstract/FREE Full Text
109. 109.↵
     1. Ohta M,
     2. Handa A,
     3. Iwata H,
     4. et al

     . Poly-vinyl alcohol hydrogel vascular models for in vitro aneurysm simulations: the key to low friction surfaces. Technol Health Care 2004;12:225–33

     PubMed
110. 110.↵
     1. Andersen P,
     2. Kjeldsen A,
     3. Nepper-Rasmussen J

     . Selective embolization in the treatment of intractable epistaxis. Acta Otolaryngol 2005;125:293–97

     CrossRefPubMed
111. 111.↵
     1. Willems P,
     2. Farb R,
     3. Agid R

     . Endovascular treatment of epistaxis. AJNR Am J Neuroradiol 2009;30:1637–45

     Abstract/FREE Full Text
112. 112.↵
     1. Gruber A,
     2. Bavinski G,
     3. Killer M,
     4. et al

     . Preoperative embolization of hypervascular skull base tumors. Minim Invasive Neurosurg 2000;43:62–71

     CrossRefPubMedWeb of Science
113. 113.↵
     1. Manelfe C,
     2. Lasjaunias P,
     3. Ruscalleda J

     . Preoperative embolization of intracranial meningiomas. AJNR Am J Neuroradiol 1986;7:963–72

     Abstract/FREE Full Text
114. 114.↵
     1. Perry A,
     2. Chicione MR,
     3. Filiput E,
     4. et al

     . Clinicopathologic assessment and grading of embolized meningiomas: a correlative study of 64 patients. Cancer 2001;92:701–11

     CrossRefPubMed
115. 115.↵
     1. Liu L,
     2. He H,
     3. Jiang C,
     4. et al

     . Deliberate parent artery occlusion for non-saccular posterior cerebral artery aneurysms. Interv Neuroradiol 2011;17:159–68

     Abstract/FREE Full Text
116. 116.↵
     1. Lv X,
     2. Li Y,
     3. Jiang C,
     4. et al

     . Parent vessel occlusion for P2 dissecting aneurysms of the posterior cerebral artery. Surg Neurol 2009;71:319–25, discussion 325

     CrossRefPubMed
117. 117.↵
     1. Pierot L,
     2. Boulin A,
     3. Castaings L,
     4. et al

     . The endovascular approach in the management of patients with multiple intracranial aneurysms. Neuroradiology 1997;39:361–66

     CrossRefPubMedWeb of Science
118. 118.↵
     1. Eckard D,
     2. O'Boynick P,
     3. McPherson C,
     4. et al

     . Coil occlusion of the parent artery for treatment of symptomatic peripheral intracranial aneurysms. AJNR Am J Neuroradiol 2000;21:137–42

     Abstract/FREE Full Text
119. 119.↵
     1. Linskey ME,
     2. Jungreis CA,
     3. Yonas H,
     4. et al

     . Stroke risk after abrupt internal carotid artery sacrifice: accuracy of preoperative assessment with balloon test occlusion and stable xenon-enhanced CT. AJNR Am J Neuroradiol 1994;15:829–43

     Abstract/FREE Full Text
120. 120.↵
     1. Kirsch M,
     2. Liebig T,
     3. Kühne D,
     4. et al

     . Endovascular management of dural arteriovenous fistulas of the transverse and sigmoid sinus in 150 patients. Neuroradiology 2009;51:477–83

     CrossRefPubMedWeb of Science
121. 121.↵
     1. Shi Z,
     2. Loh Y,
     3. Gonzalez N,
     4. et al

     . Flow control techniques for Onyx embolization of intracranial dural arteriovenous fistulae. J Neurointervent Surg 2013;5:311–16

     Abstract/FREE Full Text
122. 122.↵
     1. Quiñones D,
     2. Duckwiler G,
     3. Gobin PY,
     4. et al

     . Embolization of dural cavernous fistulas via superior ophthalmic vein approach. AJNR Am J Neuroradiol 1997;18:921–28

     Abstract/FREE Full Text
123. 123.↵
     1. Gupta AK,
     2. Periakaruppan AL

     . Intracranial dural arteriovenous fistulas: a review. Indian J Radiol Imaging 2009;19:43–48

     CrossRefPubMed
124. 124.↵
     1. Ong CK,
     2. Lam DV,
     3. Ong MT,
     4. et al

     . Neuroapplication of Amplatzer Vascular Plug for therapeutic sacrifice of major craniocerebral arteries: an initial clinical experience. Ann Acad Med Singapore 2009;38:763–68

     PubMed
125. 125.↵
     1. Gralla J,
     2. Schroth G,
     3. Kickuth R,
     4. et al

     . Closing the gap between coil and balloon in the neurointerventional armamentarium? Initial clinical experience with a nitinol vascular occlusion plug. Neuroradiology 2008;50:709–14

     CrossRefPubMedWeb of Science
126. 126.↵
     Society of Interventional Radiology Executive Council. SIR Policy on Off-Label Use. November 18, 2007. http://sirweb.org/clinical/cpg/SIR_Off-label_use_statement11–18-07.pdf. Accessed July 12, 2012